Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe Cost-effectiveness of Routine Office-based Identification and Subsequent Medical Treatment of Primary Open-Angle Glaucoma in the United States
Ophthalmology, 05/07/09
Rein DB et al. - Glaucoma treatment was highly cost-effective when the costs of diagnostic assessments were excluded or when authors assumed optimistic treatment efficacy. The cost was reasonable and in line with other health interventions even when diagnostic assessment costs were included and assuming conservative efficacy.
Related Articles
Glaucoma and dry eye data from Germany
Ophthalmology Times Europe, 10/27/09
Relevance Score: 93%
Understanding the Importance of IOP Variables in Glaucoma
Survey of Ophthalmology, 10/23/09
Relevance Score: 92%
Characteristics of respondents with glaucoma and dry eye in a national panel survey
Clinical Ophthalmology, 11/13/09
Relevance Score: 91%
Gene-directed therapy in glaucoma may have future clinical applications
Ophthalmology Times Europe, 10/22/09
Relevance Score: 91%
Sequential Glaucoma Implants in Refractory Glaucoma
American Journal of Ophthalmology, 10/20/09
Relevance Score: 91%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis
PLoS Medicine, 12/04/09
Economic Evaluation of Pharmacotherapy of Migraine Pain: A Review of the Literature
Journal Of Pain & Palliative Care Pharmacotherapy, 12/02/09
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Infection Control and Hospital Epidemiology, 12/02/09
Sponsor
Article Search
Sponsor